These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3191149)

  • 1. Degradation of intact basement membranes by human and murine tumor enzymes.
    Karakiulakis G; Missirlis E; Aletras A; Maragoudakis ME
    Biochim Biophys Acta; 1988 Nov; 967(2):163-75. PubMed ID: 3191149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mode of action of razoxane: inhibition of basement membrane collagen-degradation by a malignant tumor enzyme.
    Karakiulakis G; Missirlis E; Maragoudakis ME
    Methods Find Exp Clin Pharmacol; 1989 Apr; 11(4):255-61. PubMed ID: 2547126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basement membrane collagen-degrading activity from a malignant tumor is inhibited by anthracycline antibiotics.
    Karakiulakis G; Missirlis E; Maragoudakis ME
    Biochim Biophys Acta; 1990 Aug; 1035(2):218-22. PubMed ID: 2168213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor.
    Liotta LA; Abe S; Robey PG; Martin GR
    Proc Natl Acad Sci U S A; 1979 May; 76(5):2268-72. PubMed ID: 221920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of basement membrane collagen by proteinases from human gingiva, leukocytes and bacterial plaque.
    Uitto VJ
    J Periodontol; 1983 Dec; 54(12):740-5. PubMed ID: 6315910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative assay for the hydrolysis of structurally intact basement membranes.
    Smith C; Van Wart HE; Schwartz DE
    Anal Biochem; 1984 Jun; 139(2):448-58. PubMed ID: 6383119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells.
    Reich R; Thompson EW; Iwamoto Y; Martin GR; Deason JR; Fuller GC; Miskin R
    Cancer Res; 1988 Jun; 48(12):3307-12. PubMed ID: 2836052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of basement-membrane collagen by neutral proteases from human leukocytes.
    Uitto VJ; Schwartz D; Veis A
    Eur J Biochem; 1980 Apr; 105(2):409-17. PubMed ID: 6247153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of basement membrane matrix degradation by purified proteases and by metastatic tumor cells.
    Starkey JR; Stanford DR; Magnuson JA; Hamner S; Robertson NP; Gasic GJ
    J Cell Biochem; 1987 Sep; 35(1):31-49. PubMed ID: 3312246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular epithelial cells secrete a glomerular basement membrane-degrading metalloproteinase.
    Johnson R; Yamabe H; Chen YP; Campbell C; Gordon K; Baker P; Lovett D; Couser WG
    J Am Soc Nephrol; 1992 Mar; 2(9):1388-97. PubMed ID: 1627762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The purification and characterization of a glomerular-basement-membrane-degrading neutral proteinase from rat mesangial cells.
    Davies M; Thomas GJ; Martin J; Lovett DH
    Biochem J; 1988 Apr; 251(2):419-25. PubMed ID: 2840892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel substrate capture immunoassay for the detection of a neutral metalloproteinase capable of degrading basement membrane (type IV) collagen.
    Wacher MP; Krutzsch HC; Liotta LA; Stetler-Stevenson WG
    J Immunol Methods; 1990 Feb; 126(2):239-45. PubMed ID: 2154522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of a murine basement membrane collagen-degrading enzyme secreted by metastatic tumor cells.
    Salo T; Liotta LA; Tryggvason K
    J Biol Chem; 1983 Mar; 258(5):3058-63. PubMed ID: 6298220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials.
    Nakajima M; Welch DR; Belloni PN; Nicolson GL
    Cancer Res; 1987 Sep; 47(18):4869-76. PubMed ID: 3621180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Walker 256 tumor cell degradation of extracellular matrices involves a latent gelatinase activated by reactive oxygen species.
    Shaughnessy SG; Whaley M; Lafrenie RM; Orr FW
    Arch Biochem Biophys; 1993 Aug; 304(2):314-21. PubMed ID: 8394053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells.
    Nakajima M; Lotan D; Baig MM; Carralero RM; Wood WR; Hendrix MJ; Lotan R
    Cancer Res; 1989 Apr; 49(7):1698-706. PubMed ID: 2538232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen.
    Arthur MJ; Friedman SL; Roll FJ; Bissell DM
    J Clin Invest; 1989 Oct; 84(4):1076-85. PubMed ID: 2551922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of type IV collagen by neoplastic human skin fibroblasts.
    Sheela S; Barrett JC
    Carcinogenesis; 1985 Feb; 6(2):173-9. PubMed ID: 2982512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.
    Liotta LA; Goldfarb RH; Brundage R; Siegal GP; Terranova V; Garbisa S
    Cancer Res; 1981 Nov; 41(11 Pt 1):4629-36. PubMed ID: 6458354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 70 K type IV collagenase (gelatinase).
    Tryggvason K; Huhtala P; Höyhtya M; Hujanen E; Hurskainen T
    Matrix Suppl; 1992; 1():45-50. PubMed ID: 1480085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.